References
- Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy?Arrhythm Electrophysiol Rev. 2013;2(2):82-90.
- Chugh SS, Shen WK, Luria DM, Smith HC. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure.J Cardiovasc Electrophysiol. 2000;11(3):328-9. doi: 10.1111/ j.1540-8167.2000.tb01802.x. PMID: 10749356.
- Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter.J Am Coll Cardiol. 1998;32(1):205-210.
- Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review.J Am Coll Cardiol. 2019;73(18):2328-2344. doi:10.1016/j.jacc.2019.02.045.
- Albakri A. Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method.Integr Mol Med. 2018;5(1). doi:10.15761/imm.1000324
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
- Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy.Heart. 2017;103(19):1543-1552. doi:10.1136/ heartjnl-2016-310391.
- Perez-Silva A, Merino JL. Tachycardia-induced cardiomyopathy.E-J ESC Counc Cardiol Prac. 2009;7(16).
- Ermert L, Kreimer F, Quast DR, Pflaumbaum A, Mügge A, Gotzmann M. Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis.Front Cardiovasc Med. 2023;9. doi:10.3389/fcvm.2022.940060.
- Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB, et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.Clin Cardiol. 2008;31(4):172-178. doi:10.1002/clc.20161.
- Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy.Am J Med. 2003;114(1):51-55. doi:10.1016/S0002-9343(02)01472-9.
- Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, et al. Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.Circ J. 2007 Jun;71(6):936-40. doi: 10.1253/circj.71.936. PMID: 17526993.
- Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure.N Engl J Med. 2018;378(5):417-427. doi:10.1056/nejmoa1707855.
- Dagres N, Varounis C, Gaspar T, Piorkowski C, Eitel C, Iliodromitis EK, et al. Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.J Card Fail. 2011 Nov;17(11):964-70. doi: 10.1016/j.cardfail.2011.07.009.
- Trulock KM, Narayan SM, Piccini JP. Rhythm control in heart failure patients with atrial fibrillation contemporary challenges including the role of ablation.J Am Coll Cardiol. 2014;64(7).
- Aldaas OM, Malladi CL, Hsu JC. Catheter Ablation of atrial fibrillation in patients with heart failure.Am J Cardiol. 2019;123(1):187-195. doi:10.1016/j. amjcard.2018.09.013.
- Katritsis G, Calkins H. Catheter ablation of atrial fibrillation-techniques and technology.Arrhythm Electrophysiol Rev. 2012:29-33.
- Rabbani LE. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia.Am Heart J.1991;121(3):816-819.
- Mohamed HA. Tachycardia-induced cardiomyopathy (tachycardiomyopathy).Libyan J Med. 2007;2(1):26-29. doi:10.3402/ljm. v2i1.4688
- Prabhu S, Costello BT, Taylor AJ, Gutman SJ, Voskoboinik A, McLellan AJA, et al. Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: A substudy of the CAMERA MRI trial.JACC Clin Electrophysiol. 2018 Aug;4(8):999-1007. doi: 10.1016/j.jacep.2018.04.013.
- Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.J Am Coll Cardiol. 2012 Dec 11;60(23):2402-8. doi: 10.1016/j.jacc.2012.07.065.